Comparison of disease activity index for psoriatic arthritis (DAPSA) and minimal disease activity (MDA) targets for patients with psoriatic arthritis: A post hoc analysis of data from phase 3 tofacitinib studies-Reference-Cited by-同舟云学术

Comparison of disease activity index for psoriatic arthritis (DAPSA) and minimal disease activity (MDA) targets for patients with psoriatic arthritis: A post hoc analysis of data from phase 3 tofacitinib studies

Published:2023-02 Issue: Volume:58 Page:152134
ISSN:0049-0172
Container-title:Seminars in Arthritis and Rheumatism
language:en
Short-container-title:Seminars in Arthritis and Rheumatism

Author:

Schneeberger Emilce E.^ORCID,Citera Gustavo,Nash Peter,Smolen Josef S.,Mease Philip J.,Soriano Enrique R.,Helling Claudia,Szumski Annette E.,Mundayat Rajiv,de León Darío Ponce

Funder

Pfizer Inc

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Rheumatology

Reference39 articles.

1. Psoriatic arthritis: epidemiology, clinical features, course, and outcome;Gladman;Ann Rheum Dis,2005

2. Psoriatic arthritis;Ritchlin;N Engl J Med,2017

3. The epidemiology of psoriatic arthritis;Ogdie;Rheum Dis Clin North Am,2015

4. Prevalence of psoriatic arthritis in psoriasis patients according to newer classification criteria;Ficco;Clin Rheumatol,2014

5. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics;Mease;J Am Acad Dermatol,2013

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Additional Value of Ultrasound in Patients with Psoriatic Arthritis within Treatment Target;Journal of Clinical Medicine;2024-08-05

2. Effect of Lifestyle Counselling via a Mobile Application on Disease Activity Control in Inflammatory Arthritis: A Single-Blinded, Randomized Controlled Study;Nutrients;2024-05-14

3. Bimekizumab: Short-Term Effectiveness and Safety in Real Clinical Practice in Andalucia, Spain;Life;2024-02-20

4. Efficacy of tofacitinib in psoriatic arthritis: literature review and case report;Meditsinskiy sovet = Medical Council;2023-11-23

5. Ixekizumab Efficacy in Patients with Severe Peripheral Psoriatic Arthritis: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (SPIRIT-P1);Rheumatology and Therapy;2023-10-19